Sen. majority leader breaks with Bush on stem cells

Senate Majority Leader Bill Frist (R-Tenn.) announced his support for a bill to expand federal financing for embryonic stem cell research. Frist had said as recently as last month that he did not support changes to current limits on funding for stem-cell research, but his change of mind could break the Senate's inertia on the bill. The White House, however, has said it would veto the measure, which has already passed in the House.

- read this article from The New York Times for more

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech venture fund ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.